Key Insights from Current Research on Meta, Netflix, and Pfizer

Avatar photo

Date: February 26, 2026

The Zacks Research Daily highlights key performance updates from major stocks, including Meta Platforms, Inc. (META), Netflix, Inc. (NFLX), and Pfizer Inc. (PFE). Meta’s shares have declined by 12.5% in the last six months, although it reaches 3.58 billion daily users and reports a 30% increase in Instagram Reels watch time year-over-year. Netflix’s stock has fallen 32%, hindered by regulatory challenges related to its acquisition of Warner Bros Discovery and stiff competition, while aiming for 12-14% revenue growth in 2026. Pfizer’s shares gained 11.3% but face decline in COVID product sales alongside challenges from patent expirations and elevated debt levels.

Notably, micro-cap stocks SIFCO Industries, Inc. and Altigen Communications, Inc. showed contrasting performances. SIFCO’s shares surged 104.7% due to its resilience in the defense sector, while Altigen’s shares fell 28.7%, grappling with revenue declines and significant customer concentration risks.

The free Daily Market Overview 250k traders and investors are reading

Read Now